Immediate Impact
6 by Nobel laureates 64 standout
Citing Papers
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions
2024 Standout
Towards targeting the breast cancer immune microenvironment
2024 Standout
Works of Uwe Thuß being referenced
Rogaratinib: A potent and selective pan‐FGFR inhibitor with broad antitumor activity in FGFR‐overexpressing preclinical cancer models
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Uwe Thuß | 125 | 163 | 135 | 15 | 534 | |
| James Manis | 102 | 16 | 220 | 21 | 505 | |
| M. Stoltz | 226 | 44 | 63 | 19 | 607 | |
| Larry M. Allen | 298 | 24 | 90 | 35 | 626 | |
| Aleksandra Topić | 134 | 115 | 32 | 42 | 534 | |
| Magdalena Muszyńska | 118 | 77 | 41 | 35 | 542 | |
| Hiroyuki Ogasawara | 176 | 89 | 14 | 36 | 606 | |
| Dimitra Kareli | 89 | 56 | 17 | 17 | 464 | |
| Liv Endresen | 137 | 36 | 79 | 22 | 589 | |
| Maki Tokumoto | 124 | 54 | 32 | 36 | 536 | |
| Piotr Baszuk | 125 | 92 | 45 | 35 | 488 |
All Works
Login with ORCID to disown or claim papers
Loading papers...